WASHINGTON, Feb. 26, 2013 /PRNewswire/ -- The Board of Directors of the American Association for Clinical Chemistry (AACC) today announced that it has appointed Janet B. Kreizman Chief Executive Officer effective April 1, 2013.
Since 2009, Kreizman has served as Deputy Executive Director & Chief Policy Officer of The Endocrine Society, providing executive management for health and science policy advocacy, strategic communications, patient education, marketing, membership and governance initiatives for the $30 million organization representing more than 16,000 scientists and clinicians.
AACC President Robert H. Christenson , PhD., said, "Following a comprehensive search that considered a broad list of highly qualified candidates, Janet's unique combination of management skills, professional experience and healthcare community connections make her the ideal choice to serve as AACC's CEO. We have completed a strategic plan to chart our path forward. We are very impressed at how Janet's vision is confluent with that of the organization, and how she plans to lead AACC into the future."
Ms. Kreizman said, "I am honored to have been selected as AACC's new CEO and am excited to drive its mission of providing global leadership in advancing the practice and profession of clinical laboratory science and medicine. I look forward to working with the Board of Directors as well as AACC staff towards an exciting future focusing on value of membership, best practices, science and innovation, and global influence. Together, we will advance laboratory medicine to improve health
Copyright©2012 PR Newswire.
All rights reserved